Globeflex Capital’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35
Closed -$660 463
2024
Q4
$660 Sell
35
-7,640
-100% -$147K ﹤0.01% 427
2024
Q3
$144K Hold
7,675
0.01% 346
2024
Q2
$145K Buy
7,675
+7,610
+11,708% +$130K 0.02% 330
2024
Q1
$1.05K Hold
65
﹤0.01% 472
2023
Q4
$823 Hold
65
﹤0.01% 470
2023
Q3
$884 Buy
+65
New +$1K ﹤0.01% 456
2022
Q4
Sell
-174
Closed -$2K 522
2022
Q3
$2K Sell
174
-36,725
-100% -$522K ﹤0.01% 475
2022
Q2
$470K Hold
36,899
0.11% 222
2022
Q1
$477K Sell
36,899
-32,662
-47% -$431K 0.1% 234
2021
Q4
$1.1M Hold
69,561
0.23% 142
2021
Q3
$1.36M Sell
69,561
-79,673
-53% -$1.58M 0.3% 94
2021
Q2
$3.4M Buy
149,234
+175
+0.1% +$3.63K 0.61% 24
2021
Q1
$2.74M Sell
149,059
-7,023
-4% -$115K 0.5% 47
2020
Q4
$2.33M Buy
156,082
+2,231
+1% +$29.1K 0.5% 43
2020
Q3
$1.73M Sell
153,851
-11,404
-7% -$112K 0.46% 51
2020
Q2
$1.31M Sell
165,255
-21,722
-12% -$180K 0.33% 80
2020
Q1
$1.51M Sell
186,977
-10,925
-6% -$130K 0.46% 42
2019
Q4
$2.49M Sell
197,902
-10,133
-5% -$109K 0.47% 32
2019
Q3
$1.86M Hold
208,035
0.41% 52
2019
Q2
$1.78M Sell
208,035
-221
-0.1% -$1.75K 0.37% 66
2019
Q1
$1.58M Sell
208,256
-3,012
-1% -$24.2K 0.33% 82
2018
Q4
$1.75M Buy
211,268
+80,401
+61% +$769K 0.42% 59
2018
Q3
$1.3M Buy
130,867
+27,599
+27% +$286K 0.25% 126
2018
Q2
$1.01M Sell
103,268
-250
-0.2% -$2.46K 0.21% 169
2018
Q1
$962K Sell
103,518
-8,957
-8% -$85.3K 0.2% 180
2017
Q4
$1.07M Sell
112,475
-5,071
-4% -$48.5K 0.3% 115
2017
Q3
$1.22M Sell
117,546
-249
-0.2% -$2.3K 0.35% 88
2017
Q2
$974K Buy
+117,795
New +$884K 0.24% 167
2015
Q1
Sell
-130
Closed -$1K 587
2014
Q4
$1K Buy
+130
New +$948 ﹤0.01% 458

Other funds holding SEM

Globeflex Capital's SEM Position: Q1 2025 in Review

Globeflex Capital sold out of Select Medical (SEM) in Q1 2025, closing a stake of 35 shares — an estimated $660 sold.

Globeflex Capital first reported a position in SEM in Q4 2014 and held it in 29 quarters. The position peaked at $3.4M in Q2 2021. 274 funds tracked by Wall St. Rank hold SEM as of Q1 2025.

  • Globeflex Capital reported no remaining Select Medical position as of Q1 2025 after selling out during the quarter.
  • Globeflex Capital sold 35 Select Medical shares in Q1 2025, an estimated $660.
  • Globeflex Capital first reported a position in Select Medical in Q4 2014 and held it in 29 quarters.
  • Globeflex Capital's Select Medical position peaked at $3.4M in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Select Medical as of Q1 2025.

Based on Globeflex Capital's 13F filing for Q1 2025, filed 12 May 2025.